Genome-wide association study
(Redirected from Genome-wide association studies)
Genome-wide association study (GWAS) is a method used in genetics research to identify genes involved in human disease. This method searches the genome for small variations, called single nucleotide polymorphisms (SNPs), that occur more frequently in people with a particular disease than in people without the disease.
Overview[edit | edit source]
A GWAS is a way to identify genes and genetic variations that may contribute to a particular disease. Once new genetic associations are identified, researchers can use the information to develop better strategies to detect, treat and prevent the disease. Such studies are particularly useful in finding genetic variations that contribute to common, complex diseases, such as asthma, cancer, diabetes, heart disease and mental illnesses.
Methodology[edit | edit source]
The GWAS method involves scanning the genomes from many different people and looking for genetic markers that can be used to predict the presence of a disease. The method searches the genome for small variations, called single nucleotide polymorphisms (SNPs), that occur more frequently in people with the disease than in people without the disease.
Limitations[edit | edit source]
While GWAS studies can be very powerful, they also have several limitations. They require a large number of participants to have enough power to detect genetic associations. They can also be confounded by population stratification, where apparent associations are actually due to differences in ancestry rather than any genetic risk factor.
Future Directions[edit | edit source]
Despite these limitations, GWAS studies have been successful in identifying numerous genetic risk factors for a variety of diseases. Future research will likely focus on understanding the functional implications of these risk factors, as well as developing methods to overcome the limitations of the GWAS approach.
See also:
Genome-wide association study Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen